SecBot SecBot
8-K ·Filed May 27, 2026

MLAB

MESA LABORATORIES INC /CO/
MIXED
Impact 6/10
Horizonweeks Processed4mo ago SEC0000724004-26-000039
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The strong adjusted earnings and margin expansion (AOI margin 28.7%) should support the stock near-term, but the BPD division's 29.9% organic decline and lack of formal guidance create uncertainty. Watch for export control developments and the H1 FY2027 guidance update for a clearer trajectory. The net leverage reduction to 2.11x is a positive credit signal.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MLAB ▲ +31.43% at T+60d
NEUTRAL call +31.43% · α vs SPY +29.55% · entry $90.66 → $119.15
Entry = T+0 close
May 27, 2026
via day close
T+1d
+13.55%
call +13.55% · α +12.99%
$102.94
settled 5mo ago
T+5d
+15.13%
call +15.13% · α +14.67%
$104.38
settled 5mo ago
T+20d
+8.26%
call +8.26% · α +10.16%
$98.15
settled 4mo ago
T+60d
+31.43%
call +31.43% · α +29.55%
$119.15
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Mesa Labs reported Q4 FY2026 results with revenue of $63.7M (+2.6% YoY), slightly above the $60.9M consensus, but GAAP EPS was a loss of $(0.75), a massive miss vs the $2.55 consensus. The GAAP loss was driven by $6.7M in CEO transition costs (including $3.7M accelerated stock comp). On an adjusted basis (AOI excluding unusual items), EPS was $3.30, well above the Street consensus of $1.53. The BPD division saw a 29.9% organic revenue decline due to export controls and commercial execution issues, while SDC grew 17.7% aided by backlog clearance. No formal guidance was provided; management expects to issue guidance with H1 results. The stock will likely trade on the strong adjusted earnings and debt paydown, offset by BPD weakness and lack of near-term visibility.

Key Financial Metrics

EPS
−$0.75
est $2.55 · -129.4%
Revenue
$63.7M
est $60.9M · +4.6% · +2.6% YoY
Rating
in line
Free Cash Flow
$39.6M
Gross Margin
66.2%

Key Facts

  • Q4 revenue $63.7M, +2.6% YoY, above $60.9M consensus
  • GAAP EPS $(0.75) vs consensus $2.55 — miss driven by $6.7M CEO transition costs
  • Adjusted EPS (AOI ex unusual items) $3.30, well above Street consensus of $1.53
  • AOI ex unusual items margin 28.7%, up from 19.7% a year ago
  • BPD organic revenue declined 29.9% due to export controls and commercial execution
  • SDC organic revenue grew 17.7%, aided by ~$2.0M backlog clearance
  • Repaid $14.7M of debt; net leverage ratio reduced to 2.11x from 2.62x in Q3
  • No formal FY2027 guidance provided; management expects to issue with H1 results
  • Free cash flow for FY2026 was $39.6M, down from $42.6M in FY2025

Financial Impact

Revenue beat by ~$2.8M (4.6%) vs consensus; GAAP EPS miss of $(3.30) vs consensus; adjusted EPS beat by ~$1.77 vs Street consensus of $1.53

revenueepsoperating incomedebtfree cash flow

Risk Factors

  • BPD division revenue decline of 29.9% due to export controls and commercial execution issues
  • No formal FY2027 guidance provided; visibility limited until H1 results
  • CEO transition costs ($2.99M in Q4) may recur in early FY2027
  • Core organic revenue growth was negative (0.6%) in Q4, indicating underlying weakness
  • China CG revenue continued to contract (34% YoY decline in Q4)

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Instruments For Measurement, Display, and Control
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000724004-26-000039
Document: mlab20260526_8k.htm0000724004-26-000039
Document: 0000724004-26-000039-index-headers.html0000724004-26-000039
Document: 0000724004-26-000039-index.html0000724004-26-000039
Document: 0000724004-26-000039.txt0000724004-26-000039
8-K Data (Synthetic)0000724004-26-000039
16 reports for MLAB
Performance horizon
100% Hit rate @ T+20 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +42.54%Mar 10, 2026
Filters
Rows
Reports for MLAB — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
8-K
MIXED ★ 6/10
$127.56awaiting T+20—$129.87 (+1.81%)
Oct 13, 2026
13d ago
Press Release
MIXED ★ 6/10
$127.56awaiting T+20—$129.87 (+1.81%)
Oct 9, 2026
17d ago
SC 13G
NEUTRAL ★ 4/10
$127.51awaiting T+20—$129.87 (+1.85%)
Aug 17, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$107.64 $127.15▲ +18.13%▲ +20.10%$129.87 (+20.65%)
Aug 17, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$107.64 $127.15▲ +18.13%▲ +20.10%$129.87 (+20.65%)
Aug 17, 2026
10w ago
Insider Cluster
BULLISH ★ 5/10
$107.64 $127.15▲ +18.13%▲ +20.10%$129.87 (+20.65%)
Aug 17, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$107.64 $127.15▲ +18.13%▲ +20.10%$129.87 (+20.65%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 6/10
$111.23 $123.91▲ +11.40%▲ +12.46%$129.87 (+16.76%)
Aug 10, 2026
11w ago
Press Release
MIXED ★ 6/10
$111.23 $123.91▲ +11.40%▲ +12.46%$129.87 (+16.76%)
Jul 6, 2026
16w ago
Press Release
NEUTRAL ★ 2/10
$102.56 $100.81▼ −1.71%▼ −1.14%$129.87 (+26.63%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 4h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026